{"id":"W1549596568","doi":"10.1002/pros.22965","title":"Safety of enzalutamide in patients with metastatic castration‐resistant prostate cancer previously treated with docetaxel: Expanded access in North America","year":2015,"lang":"en","type":"article","venue":"The Prostate","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"ca_institutions":"London Health Sciences Centre; Western University; Juravinski Cancer Centre; Sunnybrook Health Science Centre; Princess Margaret Cancer Centre; BC Cancer Agency; Université de Montréal; University Health Network","funders":"National Cancer Institute; Astellas Pharma; Exelixis; Sanofi; Pfizer; Amgen","keywords":"Enzalutamide; Prostate cancer; Docetaxel; Cabazitaxel; Medicine; Adverse effect; Internal medicine; Oncology; Population; Discontinuation; Expanded access; Cancer; Urology; Androgen deprivation therapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001026018,0.0001700599,0.0004384604,0.000211082,0.000186186,0.0003797761,0.0001943371,0.0001896993,0.0009113177],"category_scores_gemma":[0.001294446,0.0001150406,0.0002967044,0.000426099,0.0002637559,0.0002119167,0.0001567459,0.0004499088,0.0001278071],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009058274,"about_ca_system_score_gemma":0.0009533869,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.004025792,"about_ca_topic_score_gemma":0.01407974,"domain_scores_codex":[0.9996222,0.0001736256,0.00002910242,0.00003591792,0.0001065166,0.00003255151],"domain_scores_gemma":[0.9984581,0.0003903536,0.0007427382,0.00003712381,0.0001645174,0.0002072093],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.03277804,0.002157109,0.5728178,0.0008892104,0.00129622,0.001236168,0.0006810295,0.001442836,0.02036419,0.0001433693,0.005176675,0.3610173],"study_design_scores_gemma":[0.004622319,0.02172185,0.9556192,0.0001724003,0.0005946934,0.003124016,0.0002062101,0.001214638,0.001856629,0.0001023738,0.01074268,0.00002299934],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9866845,0.01032147,0.000203148,0.0004865787,0.00001676352,0.00006288102,0.0002510788,0.00002601604,0.001947522],"genre_scores_gemma":[0.9956897,0.002869027,0.0002484242,0.0003791619,0.00005328322,0.00003195437,0.0004212564,0.000005948854,0.0003012425],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004025792,"threshold_uncertainty_score":0.008004725,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03335284117947412,"score_gpt":0.3166108667720986,"score_spread":0.2832580255926245,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}